Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Product/Service, Webcast, Advisory

NANOBIOTIX to Present at the 4th Annual Evercore ISI HealthCONx Conference


Regulatory News:

NANOBIOTIX (Euronext: NANO ? NASDAQ: NBTX ? the ??Company'') (Paris:NANO) (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, co-founder and chief executive officer, will participate in a virtual fireside chat at the 4th annual Evercore ISI HealthCONx Conference on Thursday, December 2, 2021, at 1:00 PM EST / 7:00 PM CET .

A link to the live audio webcast will be available on the Events section of the company's website at www.nanobiotix.com. An archived recording of the presentation will be available for 90 days.

About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company's philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris, France. The company also has subsidiaries in Cambridge, Massachusetts (United States), France, Spain, and Germany. Nanobiotix has been listed on the regulated market of Euronext in Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020.

Nanobiotix is the owner of more than 30 umbrella patents associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system. The company's resources are primarily devoted to the development of its lead product candidate? NBTXR3 ?which is the product of its proprietary oncology platform and has already achieved market authorization in Europe for the treatment of patients with soft tissue sarcoma under the brand name Hensify®.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.


These press releases may also interest you

at 05:15
Guidehouse Insights Estimates Global Revenues for Distributed Energy Resources in Commercial and Industrial Buildings Will Grow to More Than $321 Billion by 2033
A new report from Guidehouse Insights assesses the global market for distributed energy resources (DER) in commercial and industrial (C&I) buildings....

at 05:08
Sasken and JOYNEXT forge strategic partnership to accelerate innovation and expand global footprint
Sasken Technologies Limited, a leading provider of product development and digital transformation services, and JOYNEXT, a respected Tier1 player in the automotive industry, announced a strategic partnership to collaborate on the development and...

at 05:05
WORLD VOICE DAY: Explorance Encourages People Around the World to Speak out about the Challenges they Face in Higher Education or the Workplace
As part of World Voice Day on April 16, Explorance, a provider of next-gen feedback analytics solutions, is launching a new initiative encouraging everyone to speak up and use their voice to highlight the importance of creating safe spaces for...

at 05:05
Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler (pMDI) as a commitment to reducing the product's carbon footprint
Mundipharma and Vectura will now progress development of the reformulation of flutiform® (fluticasone propionate/formoterol fumarate) following long-term collaboration, planning and lab-scale development work. The reformulation will ultimately ensure...

at 05:00
IDnow bridges the AI-human divide with new expert-led video verification solution
IDnow, a leading identity verification provider in Europe, has unveiled VideoIdent Flex, a new version of its expert-led video verification service that blends advanced AI technology with human interaction. The human-based video call solution,...

at 05:00
Exyte acquires Kinetics Group to enhance global leadership in high-tech facility solutions
Exyte, a global leader in the...

More news about Science and technology...


News published on and distributed by: